Keybanc analyst Philip Gibbs maintains ATI (NYSE:ATI) with a Overweight and raises the price target from $45 to $47.
Keybanc Maintains Overweight on ATI, Raises Price Target to $47
Keybanc analyst Philip Gibbs maintains ATI (NYSE:ATI) with a Overweight and raises the price target from $45 to $47.
Related Posts
SpartanNash Boosts Dividend By 2.4%
SpartanNash Co (NASDAQ:SPTN) said its Board of Directors approved a 2.4% increase in quarterly cash dividend The revised dividend now amounts to $0.215 per…
Here’s How Much You Would Have Made Owning AMN Healthcare Services Stock In The Last 5 Years
AMN Healthcare Services (NYSE:AMN) has outperformed the market over the past 5 years by 6.49% on an annualized basis.
Quest Diagnostics And eMed Announce Collaboration For eMed Certified Guide To Supervise Testing Process For BinaxNOW COVID-19 Ag Card Home Test
eMed™, a telehealth company democratizing healthcare through digital-point-of-care solutions, and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, are